Skip to main content
TipRanks
Go Ultimate75% OFF

PDS Biotechnology (PDSB) Stock Forecast & Price Target

919 Followers
See the Price Targets and Ratings of:

PDSB Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to PDS Biotechnology in the past 3 months

PDSB Stock 12 Month Forecast

$4.50▲(387.01% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for PDS Biotechnology in the last 3 months. The average price target is $4.50 with a high forecast of $5.00 and a low forecast of $4.00. The average price target represents a 387.01% change from the last price of $0.92.
Highest Price Target$5.00Average Price Target$4.50Lowest Price Target$4.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for PDSB
Price TargetArticle
H.C. Wainwright$5buy441.13%UpsideReiterated11/13/26
B. Riley Securities$3→$4buy332.90%UpsideReiterated10/29/26
Alliance Global Partners$4.50buy387.01%UpsideReiterated04/02/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering PDS Biotechnology

3 Months
Joseph Pantginis
Joseph PantginisH.C. Wainwright
Success Rate6/14 ratings generated profit
43%
Average Return
+28.78%

Copying Joseph Pantginis's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +28.78% per trade.

1 Year
Joseph Pantginis
Joseph PantginisH.C. Wainwright
Success Rate5/14 ratings generated profit
36%
Average Return
+18.04%

Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of +18.04% per trade.

2 Years
Joseph Pantginis
Joseph PantginisH.C. Wainwright
Success Rate5/14 ratings generated profit
36%
Average Return
+22.11%

Copying Joseph Pantginis's trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of +22.11% per trade.

PDSB Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for PDSB
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy12354
Buy00000
Hold00000
Sell00000
Strong Sell00000
total12354

In the current month, PDSB has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PDSB average Analyst price target in the past 3 months is 4.50.

PDSB Financial Forecast

$-2$-1.5$-1$-0.5$0Q1 2026Q3 2026Q4 2026
High$-0.04
Consensus$-0.06
Low$-0.07

PDSB Earnings Forecast

Next quarter’s earnings estimate for PDSB is -$0.06 with a range of -$0.07 to -$0.04. The previous quarter’s EPS was -$0.11. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q1 2026Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

PDSB Sales Forecast

Next quarter’s sales forecast for PDSB is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

PDSB Stock Forecast FAQ

What is PDSB’s average 12-month price target, according to analysts?
Based on analyst ratings, PDS Biotechnology’s 12-month average price target is $4.50.
What is PDSB’s upside potential, based on the analysts’ average price target?
PDS Biotechnology has 387.01% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PDSB a Buy, Sell or Hold?
PDS Biotechnology has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is PDS Biotechnology’s price target?
The average price target for PDS Biotechnology is $4.50. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $5.00, the lowest forecast is $4.00. The average price target represents a 387.01% increase from the current price of $0.924.
What do analysts say about PDS Biotechnology?
PDS Biotechnology’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of PDSB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.